Social Drivers of COVID-19 Disease Severity in Pregnant Patients

被引:2
|
作者
Mckinney, Jennifer [1 ,3 ,5 ]
Salmanian, Bahram [1 ]
Grace, Rebecca [2 ]
Moufarrij, Sara [2 ]
Sangi-Haghpeykar, Haleh [1 ]
Eppes, Catherine [1 ,3 ]
Gandhi, Manisha [1 ,4 ]
机构
[1] Baylor Coll Med, Div Maternal Fetal Med, Houston, TX USA
[2] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX USA
[3] Harris Hlth Syst, Dept Obstet & Gynecol, Houston, TX USA
[4] Texas Childrens Hosp Pavil Women, Div Maternal Fetal Med, Houston, TX USA
[5] Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, 1504 Taub Loop, Houston, TX 77030 USA
关键词
COVID-19; pregnancy; social determinants of health; ETHNIC DISPARITIES; HEALTH; OUTCOMES; INFECTION;
D O I
10.1055/a-2109-3876
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective While coronavirus disease 2019 (COVID-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had global impact in all populations, certain groups of patients have experienced disproportionate rates of morbidity and mortality. The purpose of this study was to assess the relationship between COVID-19 disease severity, demographic variables, race and ethnicity, and social determinants of health among pregnant patients in a diverse urban population.Study Design A retrospective analysis was performed of all pregnant patients diagnosed with COVID-19 at two urban tertiary care centers in Houston, TX between March and August 2020. Maternal demographic, COVID-19 illness criteria, and delivery characteristics were collected. The Centers for Disease Control and Prevention Social Vulnerability Index (SVI) and COVID-19 Community Vulnerability Index (CCVI) were obtained based on a patients' census tract of residence. Analyses compared persons with asymptomatic, mild, or severe-critical disease at diagnosis.Results A total of 317 persons tested positive for COVID-19 during this time period. Asymptomatic persons were more likely to be diagnosed at later gestational ages, but there were no other differences in baseline maternal characteristics. Persons with more severe disease had greater social vulnerability specifically for housing and transportation than those with mild disease (mean SVI [standard error]: 0.72 [0.06] vs. 0.58 [0.2], p = 0.03). Total SVI, total CCVI, and other themed SVI and CCVI indices were not significantly different between groups.Conclusion In this cohort of pregnant persons infected with SARS-CoV-2, an association was shown between disease severity and increased vulnerability in living conditions and transportation. Drivers of the pandemic and COVID-19 outcomes are complex and multifactorial, and likely change over time. However, continued efforts to accurately identify and measure social determinants of health in medicine will likely help identify geographic areas and patient populations that are at risk of higher disease burden. This could facilitate preventative and mitigation measures in these areas in future disaster or pandemic situations.
引用
收藏
页码:e2269 / e2278
页数:10
相关论文
共 50 条
  • [21] COVID disease severity: comparing demographics and social vulnerability indices for pregnant patients
    McKinney, Jennifer R.
    Salmanian, Bahram
    Grace, Rebecca
    Moufarrij, Sara
    Sangi-Haghpeykar, Haleh
    Gandhi, Manisha
    Eppes, Catherine
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S639 - S640
  • [22] Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19
    Husain-Syed, Faeq
    Vadasz, Istvan
    Wilhelm, Jochen
    Walmrath, Hans-Dieter
    Seeger, Werner
    Birk, Horst-Walter
    Jennert, Birgit
    Dietrich, Hartmut
    Herold, Susanne
    Trauth, Janina
    Tello, Khodr
    Sander, Michael
    Morty, Rory E.
    Slanina, Heiko
    Schuttler, Christian G.
    Ziebuhr, John
    Kassoumeh, Shadi
    Ronco, Claudio
    Ferrari, Fiorenza
    Warnatz, Klaus
    Stahl, Klaus
    Seeliger, Benjamin
    Hoeper, Marius M.
    Welte, Tobias
    David, Sascha
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2021, 320 (04) : L590 - L599
  • [23] Homocysteine as a marker for predicting disease severity in patients with COVID-19
    Keskin, Adem
    Ustun, Goksenin U.
    Aci, Recai
    Duran, Utku
    BIOMARKERS IN MEDICINE, 2022, 16 (07) : 559 - 568
  • [24] A single transcript for the prognosis of disease severity in COVID-19 patients
    Lei, Hongxing
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [25] IMMATURE PLATELETS AND DISEASE SEVERITY IN HOSPITALIZED PATIENTS WITH COVID-19
    Urrechaga, Eloisa
    Fernandez, Monica
    Merino, Monica
    Mugertza, Garazi
    Ponga, Cristina
    Naharro, Imanol
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 120 - 121
  • [26] Potential Predictors for Disease Severity in Hospitalised COVID-19 Patients
    Gysan, M.
    Bal, C.
    Milacek, C.
    Zech, A.
    Brugger, J.
    Milos, R.
    Antoniewicz, L.
    Idzko, M.
    Gompelmann, D.
    PNEUMOLOGIE, 2023, 77 : S105 - S105
  • [27] COVID-19 Severity in Hospitalized Pediatric Patients with Atopic Disease
    Timberlake, Dylan
    Scherzer, Rebecca
    Prince, Benjamin
    Grayson, Mitchell
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB79 - AB79
  • [28] A single transcript for the prognosis of disease severity in COVID-19 patients
    Hongxing Lei
    Scientific Reports, 11
  • [29] Immature platelets in patients with Covid-19: association with disease severity
    Amir Cohen
    Emanuel Harari
    Ella Yahud
    Michal Cipok
    Gabriel Bryk
    Nili Karp Lador
    Tal Mann
    Ami Mayo
    Eli I. Lev
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 708 - 714
  • [30] Severity of COVID-19 in hospitalized patients with and without atopic disease
    Timberlake, Dylan T.
    Narayanan, Deepika
    Ogbogu, Princess U.
    Raveendran, Rekha
    Porter, Kyle
    Scherzer, Rebecca
    Prince, Benjamin
    Grayson, Mitchell H.
    WORLD ALLERGY ORGANIZATION JOURNAL, 2021, 14 (02):